{"transactions":[{"id":925518,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2026-02-02T16:30:08.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":195000,"derivative":{"exercise_price":0.44,"expiration_date":"2036-02-01","underlying":"American Depository Shares","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001193125-26-033753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000119312526033753/ownership.xml","form_type":"4"}},{"id":925517,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2026-02-02T16:30:08.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":61250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":61250,"derivative":{"exercise_price":1,"expiration_date":"2036-02-01","underlying":"American Depository Shares","underlying_shares":61250},"source":{"system":"sec-edgar","filing":"0001193125-26-033753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000119312526033753/ownership.xml","form_type":"4"}},{"id":925516,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2026-02-02T16:30:08.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":183750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":183750,"derivative":{"exercise_price":0.44,"expiration_date":"2036-02-01","underlying":"American Depositary Shares","underlying_shares":183750},"source":{"system":"sec-edgar","filing":"0001193125-26-033753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000119312526033753/ownership.xml","form_type":"4"}},{"id":1293252,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2025-01-28T16:05:07.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":154000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":154000,"derivative":{"exercise_price":2.91,"expiration_date":"2035-01-25","underlying":"American Depository Shares","underlying_shares":154000},"source":{"system":"sec-edgar","filing":"0000950170-25-009789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017025009789/ownership.xml","form_type":"4"}},{"id":1406842,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-16T20:46:34.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":84008,"price":4.221,"value":354597.768,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person sold a total of 124,037 ADSs solely to pay tax obligations, including tax withholding obligations related to the exercise of stock options described in the Form 4 filed on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.01 to $4.43, inclusive."}],"balance_after":50475,"source":{"system":"sec-edgar","filing":"0000950170-24-106968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106968/ownership.xml","form_type":"4"}},{"id":1406841,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-16T20:46:34.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":16304,"price":4.221,"value":68819.184,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the 'Plan'), occurring on September 11, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.01 to $4.43, inclusive."}],"balance_after":134483,"source":{"system":"sec-edgar","filing":"0000950170-24-106968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106968/ownership.xml","form_type":"4"}},{"id":1406840,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-16T20:46:34.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":40029,"price":4.4727,"value":179037.7083,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person sold a total of 124,037 ADSs solely to pay tax obligations, including tax withholding obligations related to the exercise of stock options described in the Form 4 filed on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.37 to $4.62, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc (\"Mereo\"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."}],"balance_after":150787,"source":{"system":"sec-edgar","filing":"0000950170-24-106968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106968/ownership.xml","form_type":"4"}},{"id":1406839,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-16T20:46:34.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":7769,"price":4.4727,"value":34748.4063,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the 'Plan'), occurring on September 11, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.37 to $4.62, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc (\"Mereo\"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The total amount of securities beneficially owned on the reporting person's Form 4 filed on September 13, 2024 has been reduced by 44,296, which reflects ADSs withheld by the Issuer in connection with the net settlement of the stock option exercise on September 11, 2024 and inadvertently omitted from the September 13, 2024 filing. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3."}],"balance_after":190816,"source":{"system":"sec-edgar","filing":"0000950170-24-106968","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106968/ownership.xml","form_type":"4"}},{"id":1407879,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":false,"shares":75000,"price":1.01,"value":75750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.01,"expiration_date":"2033-01-25","underlying":"American Depository Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1407878,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":false,"shares":93333,"price":1.4,"value":130666.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2032-01-14","underlying":"American Depository Shares","underlying_shares":93333},"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1407877,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance Based Restricted Stock Unit","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-09-11","expiration_date":"2025-01-25","underlying":"American Depository Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1407876,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":true,"shares":75000,"price":1.01,"value":75750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":242881,"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1407875,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":true,"shares":93333,"price":1.4,"value":130666.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":167881,"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1407874,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-09-13T16:47:50.000Z","date":"2024-09-11","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock unit earned under the issuer's 2019 Employee Incentive Plan (the \"Plan\"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period."}],"balance_after":74548,"source":{"system":"sec-edgar","filing":"0000950170-24-106413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024106413/ownership.xml","form_type":"4"}},{"id":1468269,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-06-27T16:15:03.000Z","date":"2024-06-26","kind":"sale","planned":false,"acquired":false,"shares":22968,"price":3.3932,"value":77935.0176,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the \"Plan\"), that vested on June 21, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $3.28 to $3.51, inclusive."}],"balance_after":34548,"source":{"system":"sec-edgar","filing":"0000950170-24-078462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024078462/ownership.xml","form_type":"4"}},{"id":1468268,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-06-27T16:15:03.000Z","date":"2024-06-25","kind":"sale","planned":false,"acquired":false,"shares":10134,"price":3.6939,"value":37433.9826,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the \"Plan\"), that vested on June 21, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $3.60 to $3.805, inclusive. The Reporting\nPerson undertakes to provide to Mereo BioPharma Group plc (\"Mereo\"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."}],"balance_after":57516,"source":{"system":"sec-edgar","filing":"0000950170-24-078462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024078462/ownership.xml","form_type":"4"}},{"id":1469691,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance Based Restricted Stock Unit","published_at":"2024-06-25T18:13:43.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":40000,"derivative":{"exercise_price":0,"exercise_date":"2024-06-21","expiration_date":"2025-01-25","underlying":"American Depository Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-077479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024077479/ownership.xml","form_type":"4"}},{"id":1469690,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-06-25T18:13:43.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock unit (\"PSU\") earned under the issuer's 2019 Employee Incentive Plan (the \"Plan\") that vested on June 21, 2024 based on satisfaction of ADS price threshold values over a two year performance period (expiring on January 1, 2025)."}],"balance_after":67650,"source":{"system":"sec-edgar","filing":"0000950170-24-077479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024077479/ownership.xml","form_type":"4"}},{"id":1503986,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"exercise","planned":false,"acquired":false,"shares":75000,"price":1.01,"value":75750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.01,"expiration_date":"2033-01-25","underlying":"American Depositary Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503985,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"exercise","planned":false,"acquired":false,"shares":93333,"price":1.4,"value":130666.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2032-01-14","underlying":"American Depositary Shares","underlying_shares":93333},"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503984,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":24918,"price":1.01,"value":25167.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."}],"balance_after":7650,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503983,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"sale","planned":false,"acquired":false,"shares":50082,"price":2.94,"value":147241.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges"}],"balance_after":32568,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503982,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"exercise","planned":false,"acquired":true,"shares":75000,"price":1.01,"value":75750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."}],"balance_after":82650,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503981,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":42983,"price":1.4,"value":60176.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."}],"balance_after":7650,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503980,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"sale","planned":false,"acquired":false,"shares":50350,"price":2.99,"value":150546.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges"}],"balance_after":58633,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1503979,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2024-05-23T21:54:37.000Z","date":"2024-05-22","kind":"exercise","planned":false,"acquired":true,"shares":93333,"price":1.4,"value":130666.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes."}],"balance_after":100983,"source":{"system":"sec-edgar","filing":"0000950170-24-064274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024064274/ownership.xml","form_type":"4"}},{"id":1669837,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":68234,"kind":"person","name":"Hughes-Wilson Alexandra","position":1,"cik":"0002005875","reported_name":"Hughes-Wilson Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Options (Right to buy)","published_at":"2024-01-26T16:15:15.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this share option will vest and become exercisable on January 25, 2025, with the remainder vesting in equal monthly installments for the three years thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":196000,"derivative":{"exercise_price":3.36,"expiration_date":"2034-01-25","underlying":"American Depository Shares","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0000950170-24-007937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005875/000095017024007937/ownership.xml","form_type":"4"}}]}